Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (543) 543
Patent (93) 93
Publication (17) 17
Magazine Article (15) 15
Book Chapter (3) 3
Book / eBook (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (379) 379
science & technology (369) 369
life sciences & biomedicine (354) 354
female (276) 276
oncology (236) 236
middle aged (228) 228
aged (191) 191
adult (186) 186
biological and medical sciences (186) 186
medical sciences (176) 176
male (168) 168
tumors (116) 116
prognosis (100) 100
aged, 80 and over (88) 88
abridged index medicus (74) 74
breast neoplasms - pathology (71) 71
human necessities (71) 71
medicin och hälsovetenskap (70) 70
hygiene (69) 69
medical or veterinary science (69) 69
breast cancer (66) 66
cancer (63) 63
preparations for medical, dental, or toilet purposes (62) 62
treatment outcome (53) 53
chemistry (52) 52
specific therapeutic activity of chemical compounds ormedicinal preparations (52) 52
heterocyclic compounds (51) 51
metallurgy (51) 51
organic chemistry (51) 51
survival analysis (45) 45
survival rate (45) 45
gynecology. andrology. obstetrics (43) 43
antineoplastic agents - therapeutic use (42) 42
imatinib mesylate (41) 41
flow cytometry (40) 40
risk factors (40) 40
breast neoplasms - drug therapy (38) 38
follow-up studies (38) 38
radiology, nuclear medicine & medical imaging (37) 37
disease-free survival (36) 36
antineoplastic agents (35) 35
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
neoplasm staging (35) 35
pharmacology. drug treatments (35) 35
benzamides (34) 34
chemotherapy (34) 34
medical and health sciences (34) 34
breast neoplasms - mortality (33) 33
gastrointestinal stromal tumors - drug therapy (33) 33
pathology (33) 33
research (33) 33
immunohistochemistry (32) 32
mammary gland diseases (32) 32
dna, neoplasm - analysis (31) 31
pyrimidines - therapeutic use (31) 31
adolescent (30) 30
multivariate analysis (30) 30
piperazines - therapeutic use (30) 30
prospective studies (30) 30
surgery (30) 30
chemotherapy, adjuvant (29) 29
hematology, oncology and palliative medicine (29) 29
mutation (29) 29
radiotherapy (29) 29
3122 cancers (28) 28
clinical medicine (28) 28
general & internal medicine (28) 28
klinisk medicin (28) 28
animals (27) 27
breast neoplasms - metabolism (27) 27
finland (27) 27
medicine, general & internal (27) 27
cancer och onkologi (26) 26
hematologic and hematopoietic diseases (26) 26
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (26) 26
survival (26) 26
time factors (26) 26
breast neoplasms - genetics (25) 25
cancer and oncology (25) 25
care and treatment (25) 25
combined modality therapy (25) 25
neoplasms (25) 25
imatinib (24) 24
ploidies (23) 23
gastroenterology. liver. pancreas. abdomen (22) 22
measuring (22) 22
medicine (22) 22
patients (22) 22
physics (22) 22
proto-oncogene proteins c-kit - genetics (22) 22
testing (22) 22
cohort studies (21) 21
diagnosis (21) 21
gastrointestinal neoplasms - drug therapy (21) 21
hematology (21) 21
research article (21) 21
cell line, tumor (20) 20
trastuzumab (20) 20
aneuploidy (19) 19
stomach. duodenum. small intestine. colon. rectum. anus (19) 19
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (639) 639
French (23) 23
Finnish (17) 17
German (14) 14
Chinese (6) 6
Portuguese (6) 6
Swedish (5) 5
Norwegian (4) 4
Spanish (4) 4
Polish (3) 3
Danish (2) 2
Slovenian (2) 2
Czech (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Risk stratification of patients diagnosed with gastrointestinal stromal tumor
by Joensuu, Heikki, MD, PhD
Human pathology, ISSN 0046-8177, 2008, Volume 39, Issue 10, pp. 1411 - 1419
Pathology | Gastrointestinal stromal tumors | Adjuvant therapy | Risk stratification | NIH consensus classification system | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Investigative techniques, diagnostic techniques (general aspects) | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Biological and medical sciences | Medical sciences | Tumors | Gastrointestinal Stromal Tumors - classification | Intestinal Neoplasms - mortality | Prognosis | Stomach Neoplasms - diagnosis | Intestine, Small - pathology | Risk Assessment | Mitosis | United States | Humans | Survival Rate | National Institutes of Health (U.S.) | Gastrointestinal Stromal Tumors - diagnosis | Intestinal Neoplasms - classification | Consensus Development Conferences, NIH as Topic | Retrospective Studies | Gastrointestinal Stromal Tumors - mortality | Intestinal Neoplasms - diagnosis | Stomach Neoplasms - classification | Stomach Neoplasms - mortality | Health aspects | Confidence intervals | Risk assessment | Classification | Clinical trials | Mutation | Medical diagnosis | Multivariate analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Escalating and de-escalating treatment in HER2-positive early breast cancer
by Joensuu, Heikki
Cancer treatment reviews, ISSN 0305-7372, 2016, Volume 52, pp. 1 - 11
Hematology, Oncology and Palliative Medicine | Human epidermal growth factor receptor 2 | Breast cancer | Trastuzumab | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - enzymology | Humans | Receptor, ErbB-2 - metabolism | Female | Trastuzumab - administration & dosage | Chemotherapy, Adjuvant | Randomized Controlled Trials as Topic | Epidermal growth factor | Adjuvant treatment | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Gastrointestinal stromal tumour
by Joensuu, Heikki, Prof and Hohenberger, Peter, MD and Corless, Christopher L, MD
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9896, pp. 973 - 983
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | General aspects | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | Gastrointestinal Neoplasms - genetics | Humans | Chondroma - genetics | Antineoplastic Agents - therapeutic use | Piperazines - therapeutic use | Gastrointestinal Neoplasms - therapy | Mutation - genetics | Imatinib Mesylate | Preoperative Care | Gastrointestinal Neoplasms - pathology | Gastrointestinal Stromal Tumors - therapy | Benzamides - therapeutic use | Pyrimidines - therapeutic use | Receptor, Platelet-Derived Growth Factor alpha - genetics | Gastrointestinal Stromal Tumors - pathology | Paraganglioma, Extra-Adrenal - genetics | Leiomyosarcoma - genetics | Proto-Oncogene Proteins c-kit - genetics | Neurofibromatosis 1 - genetics | Gastrointestinal Stromal Tumors - genetics | Gastrointestinal tumors | Clinical trials | Dehydrogenases | Mutation | Surgery | Colorectal cancer | Abdomen | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Adjuvant treatment of GIST: Patient selection and treatment strategies
by Joensuu, Heikki
Nature reviews. Clinical oncology, ISSN 1759-4774, 06/2012, Volume 9, Issue 6, pp. 351 - 358
Life Sciences & Biomedicine | Oncology | Science & Technology | Adjuvants, Immunologic | Gastrointestinal Stromal Tumors - drug therapy | Pyrimidines - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Piperazines - therapeutic use | Benzamides | Chemotherapy, Adjuvant | Imatinib Mesylate | Patient Selection | Antimitotic agents | Relapse | Gastrointestinal tumors | Research | Drug therapy | Antineoplastic agents | Health aspects | Risk factors | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Adaptive Randomization of Neratinib in Early Breast Cancer
by Joensuu, Heikki
The New England journal of medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 16, pp. 1592 - 1592
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text To the editor
by Joensuu, Heikki
The New England journal of medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 16, p. 1592
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Dual targeting of HER2 with lapatinib and trastuzumab
by Joensuu, Heikki
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1050 - 1052
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Antibodies, Monoclonal, Humanized - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Quinazolines - therapeutic use | Humans | Female | Neoadjuvant Therapy | Breast Neoplasms - drug therapy | Trastuzumab | Antimitotic agents | Antineoplastic agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Duration of adjuvant trastuzumab: shorter beats longer
by Joensuu, Heikki
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9897, pp. 1010 - 1011
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - administration & dosage | Humans | Receptor, ErbB-2 - metabolism | Female | Antineoplastic Agents - administration & dosage | Breast Neoplasms - drug therapy | Trastuzumab | Cancer therapies | Chemotherapy | Breast cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Adjuvant Therapy for High-Risk Gastrointestinal Stromal Tumour
: Considerations for Optimal Management
by Joensuu, Heikki
Drugs (New York, N.Y.), ISSN 0012-6667, 11/2012, Volume 72, Issue 15, pp. 1953 - 1963
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Gastrointestinal-stromal-tumours | Adjuvants | Protein-tyrosine- kinase-inhibitors | Imatinib | Risk-management | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Medical sciences | Tumors | Piperazines - administration & dosage | Gastrointestinal Neoplasms - drug therapy | Pyrimidines - administration & dosage | Humans | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Imatinib Mesylate | Piperazines - adverse effects | Randomized Controlled Trials as Topic | Disease-Free Survival | Gastrointestinal Neoplasms - pathology | Protein Kinase Inhibitors - administration & dosage | Animals | Antineoplastic Agents - adverse effects | Gastrointestinal Stromal Tumors - drug therapy | Gastrointestinal Stromal Tumors - pathology | Pyrimidines - adverse effects | Disease Management | Benzamides | Chemotherapy, Adjuvant | Treatment outcome | Drug therapy | Gastrointestinal tumors | Risk factors | Index Medicus | Drugs | Pathology | Compliance | Mutation | Stratification | Survival | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Systemic chemotherapy for cancer: from weapon to treatment
by Joensuu, Heikki, Prof
The lancet oncology, ISSN 1470-2045, 2008, Volume 9, Issue 3, pp. 304 - 304
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | History, 20th Century | Humans | Mechlorethamine - adverse effects | Mechlorethamine - therapeutic use | Chemical Warfare Agents - adverse effects | Antineoplastic Agents, Alkylating - therapeutic use | Mechlorethamine - history | Antineoplastic Agents, Alkylating - history | Hodgkin Disease - drug therapy | Female | Antineoplastic Agents, Alkylating - adverse effects | Hodgkin Disease - history | Chemical Warfare Agents - history | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights